Elevance Health stock loses 2.56 percent pre-market to EUR 352.60
Published on 10/09/2026 at 08:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- Elevance Health stock was EUR 352.60 pre-market, down 2.56 percent.
- Lang & Schwarz recorded a bid of EUR 350.00 and an ask of EUR 355.20.
- Elevance Health is scheduled to report third-quarter results on October 21, 2026.
Elevance Health stock was at EUR 352.60 pre-market at 8:29 a.m. CEST on October 9, 2026, down 2.56 percent versus the prior close at Lang & Schwarz of EUR 361.85 on October 8, 2026.
Pre-market trading
Lang & Schwarz showed a bid of EUR 350.00 and an ask of EUR 355.20, a spread of EUR 5.20. The Xetra session is scheduled to begin at 9:00 a.m. CEST, after the pre-market indication. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Elevance Health stock.
What matters today
Elevance Health is scheduled to release its third-quarter 2026 results on October 21, 2026, at 6:00 a.m. EDT. A move to the round level of EUR 400.00 would be 13.44 percent above the pre-market price. The P/E was 17.97 as of October 8, 2026, according to US Stocks Today.
Trading reference
The current indication remains below the October 8 Lang & Schwarz close, with the quoted bid and ask defining a pre-market range around the last traded indication. The scheduled results date is the next company-specific calendar item identified for Elevance Health, while the valuation figure provides a dated reference for the stock before the Xetra session.
Market context: Market report S&P 500.
